Bo Li
- Cancer Research top 2%
- MicroRNA in disease regulation 33
- Cancer-related molecular mechanisms research 23
- Neurology top 2%
- Biological Psychiatry top 5%
-
- Spine and Intervertebral Disc Pathology 15
- Spinal Cord Injury Research 12
- Developmental Neuroscience top 5%
-
- Circular RNAs in diseases 25
-
- Spinal Fractures and Fixation Techniques 18
- Pelvic and Acetabular Injuries 12
-
- Nerve injury and regeneration 16
- Co-authors
- Shiqing FengDe‐Shu ShangWen‐Gang FangYuhua ChenChao SunXiaohong KongBaoyou FanHuiquan Duan
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bo Li
287 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 179
- Cancer Research 971
- Neurology 401
- Biological Psychiatry 114
- Pathology and Forensic Medicine 703
- Developmental Neuroscience 129
Countries citing papers authored by Bo Li
This map shows the geographic impact of Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Li more than expected).
Fields of papers citing papers by Bo Li
This network shows the impact of papers produced by Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Li. The network helps show where Bo Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 27 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 52 | |
| 11 | 2019 | 11 | |
| 12 | 2019 | 31 | |
| 13 | 2018 | 34 | |
| 14 | 2017 | 2 | |
| 15 | [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.] | 2016 | 3 |
| 16 | 2016 | 1 | |
| 17 | 2014 | 17 | |
| 18 | [Report of a child with neonatal-onset multisystem inflammatory disease and review of the literature]. | 2014 | 1 |
| 19 | 2014 | 29 | |
| 20 | [Electromyographic activity of sternocleidomastoid and masticatory muscle in patients with prognathism]. | 2011 | 1 |
About Bo Li
Bo Li is a scholar working on Cancer Research, Neurology and Pathology and Forensic Medicine, having authored 308 papers that have together received 5.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (33 papers), Circular RNAs in diseases (25 papers), Cancer-related molecular mechanisms research (23 papers), Spinal Fractures and Fixation Techniques (18 papers), Nerve injury and regeneration (16 papers), Spine and Intervertebral Disc Pathology (15 papers), Pelvic and Acetabular Injuries (12 papers) and Spinal Cord Injury Research (12 papers). The work is most often cited by research in Cancer Research (971 citations), Neurology (401 citations) and Biological Psychiatry (114 citations). Bo Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shiqing Feng, De‐Shu Shang, Wen‐Gang Fang, Yuhua Chen, Chao Sun, Xiaohong Kong, Baoyou Fan, Huiquan Duan, Wei‐Dong Zhao and Jian Hao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.